{
     "PMID": "28315273",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170926",
     "LR": "20170926",
     "IS": "0065-2598 (Print) 0065-2598 (Linking)",
     "VI": "964",
     "DP": "2017",
     "TI": "Stimulation of the Sigma-1 Receptor and the Effects on Neurogenesis and Depressive Behaviors in Mice.",
     "PG": "201-211",
     "LID": "10.1007/978-3-319-50174-1_14 [doi]",
     "AB": "Sigma-1 receptor (Sig-1R) is molecular chaperone regulating calcium efflux from the neuronal endoplasmic reticulum to mitochondria. Recent studies show that Sig-1R stimulation antagonizes depressive-like behaviors in animal models, but molecular mechanisms underlying this effect remain unclear. Here, we focus on the effects of Sig-1R ligands on hippocampal neurogenesis and depressive-like behaviors. Sig-1R stimulation also enhances CaMKII /CaMKIV and protein kinase B (Akt) activities in hippocampus. Therefore, we discuss the fundamental roles of Sig-1R, CaMKII /CaMKIV and protein kinase B (Akt) signaling in amelioration of depressive-like behaviors following Sig-1R stimulation.",
     "FAU": [
          "Fukunaga, Kohji",
          "Moriguchi, Shigeki"
     ],
     "AU": [
          "Fukunaga K",
          "Moriguchi S"
     ],
     "AD": "Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan. kfukunaga@m.tohoku.ac.jp. Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, 6-3 Aramaki-Aoba, Aoba-ku, Sendai, Miyagi, 980-8578, Japan.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Review"
     ],
     "PL": "United States",
     "TA": "Adv Exp Med Biol",
     "JT": "Advances in experimental medicine and biology",
     "JID": "0121103",
     "RN": [
          "0 (Ligands)",
          "0 (Receptors, sigma)",
          "0 (sigma-1 receptor)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "EC 2.7.11.17 (Calcium-Calmodulin-Dependent Protein Kinase Type 2)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Behavior, Animal/*physiology",
          "Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism",
          "Depression/*metabolism",
          "Hippocampus/metabolism",
          "Humans",
          "Ligands",
          "Mice",
          "Neurogenesis/*physiology",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Receptors, sigma/*metabolism",
          "Signal Transduction/physiology"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "*BDNF",
          "*CaMKII",
          "*CaMKIV",
          "*Depression",
          "*Neurogenesis",
          "*Sigma-1 receptor"
     ],
     "EDAT": "2017/03/21 06:00",
     "MHDA": "2017/09/28 06:00",
     "CRDT": [
          "2017/03/19 06:00"
     ],
     "PHST": [
          "2017/03/19 06:00 [entrez]",
          "2017/03/21 06:00 [pubmed]",
          "2017/09/28 06:00 [medline]"
     ],
     "AID": [
          "10.1007/978-3-319-50174-1_14 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Adv Exp Med Biol. 2017;964:201-211. doi: 10.1007/978-3-319-50174-1_14.",
     "term": "hippocampus"
}